Hersh EM - Search Results

1

Phase I-II trial of percutaneous intra-arterial cis-diamminedichloro platinum (II) for regionally confined malignancy.

Calvo DB 3rd, Patt YZ, Wallace S, Chuang VP, Benjamin RS, Pritchard JD, Hersh EM, Bodey GP Sr, Mavligit GM. Calvo DB 3rd, et al. Among authors: hersh em. Cancer. 1980 Mar 15;45(6):1278-83. doi: 10.1002/1097-0142(19800315)45:6<1278::aid-cncr2820450603>3.0.co;2-i. Cancer. 1980. PMID: 7188880

2

Intraarterial cis-platinum for patients with inoperable skeletal tumors.

Mavligit GM, Benjamin R, Patt YZ, Jaffe N, Chuang V, Wallace S, Murray J, Ayala A, Johnston S, Hersh EM, Calvo DB 3rd. Mavligit GM, et al. Among authors: hersh em. Cancer. 1981 Jul 1;48(1):1-4. doi: 10.1002/1097-0142(19810701)48:1<1::aid-cncr2820480102>3.0.co;2-r. Cancer. 1981. PMID: 6263447 Clinical Trial.

3

Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.

Patt YZ, Mavligit GM, Chuang VP, Wallace S, Johnston S, Benjamin RS, Valdivieso M, Hersh EM. Patt YZ, et al. Among authors: hersh em. Cancer. 1980 Jul 15;46(2):261-5. doi: 10.1002/1097-0142(19800715)46:2<261::aid-cncr2820460207>3.0.co;2-0. Cancer. 1980. PMID: 6446376

4

The palliative role of hepatic arterial infusion and arterial occlusion in colorectal carcinoma metastatic to the liver.

Patt YZ, Chuang VP, Wallace S, Hersh EM, Freireich EJ, Mavligit GM. Patt YZ, et al. Among authors: hersh em. Lancet. 1981 Feb 14;1(8216):349-50. doi: 10.1016/s0140-6736(81)91671-8. Lancet. 1981. PMID: 6162066

5

Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma.

Robidoux A, Gutterman JU, Bodey GP Sr, Hersh EM. Robidoux A, et al. Among authors: hersh em. Cancer. 1982 Jun 1;49(11):2246-51. doi: 10.1002/1097-0142(19820601)49:11<2246::aid-cncr2820491108>3.0.co;2-d. Cancer. 1982. PMID: 7042068 Clinical Trial.

6

Cellular immune modulation after a single high dose of Levamisole in patients with carcinoma.

Lewinski UH, Mavligit GM, Hersh EM. Lewinski UH, et al. Among authors: hersh em. Cancer. 1980 Nov 15;46(10):2185-94. doi: 10.1002/1097-0142(19801115)46:10<2185::aid-cncr2820461015>3.0.co;2-5. Cancer. 1980. PMID: 7427861

7

Evaluation of vindesine and MER in colorectal cancer.

Bedikian AY, Valdivieso M, Maroun J, Gutterman JU, Hersh EM, Bodey GP. Bedikian AY, et al. Among authors: hersh em. Cancer. 1980 Aug 1;46(3):463-7. doi: 10.1002/1097-0142(19800801)46:3<463::aid-cncr2820460307>3.0.co;2-p. Cancer. 1980. PMID: 6249481

8

Immunotherapy with levamisole: early decrease of cAMP levels in lymphocytes from treated cancer patients.

Lewinski UH, Mavligit GM, Thompson WJ, Hersh EM, Ortez RA. Lewinski UH, et al. Among authors: hersh em. Cancer. 1979 Oct;44(4):1280-3. doi: 10.1002/1097-0142(197910)44:4<1280::aid-cncr2820440417>3.0.co;2-1. Cancer. 1979. PMID: 227560

9

Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.

Hortobagyi GN, Blumenschein GR, Tashima CK, Buzdar AU, Burgess MA, Livingston RB, Valdivieso M, Gutterman JU, Hersh EM, Bodey GP. Hortobagyi GN, et al. Among authors: hersh em. Cancer. 1979 Aug;44(2):398-405. doi: 10.1002/1097-0142(197908)44:2<398::aid-cncr2820440205>3.0.co;2-t. Cancer. 1979. PMID: 383255

10

Inhibition of human lymphoma cell-line colony formation by lymphocytes from patients with lymphoma and cancer hospital employees.

Drewinko B, Mavligit GM, Ambus U, Hersh EM. Drewinko B, et al. Among authors: hersh em. Cancer. 1976 Jun;37(6):2929-37. doi: 10.1002/1097-0142(197606)37:6<2929::aid-cncr2820370650>3.0.co;2-p. Cancer. 1976. PMID: 779948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

450 results

Search Page